Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…
Media Release SYDNEY, AUSTRALIA, July 28, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Media Release SYDNEY, AUSTRALIA, July 28, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Ms. Sullivan brings her extensive commercialization, strategy, and market access experience to the Lexicon Board…
Ms. Sullivan brings her extensive commercialization, strategy, and market access experience to the Lexicon Board…
SEATTLE, July 28, 2023 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
SEATTLE, July 28, 2023 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
Customer Cash Receipts (A$’000) Customer Cash Receipts (A$’000) MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE)…
Customer Cash Receipts (A$’000) Customer Cash Receipts (A$’000) MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE)…
CLEVELAND, July 28, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that…